7CS517 Analytics Ethics Trust and Governance Assignment Sample

Medical Organizations
- Medical samples providing

Data analytics furnishes medical organizations’ associations with the ability to attract experiences from clinical information requests to pursue choices that are more educated, work on quiet results, and upgrade costs. By utilizing prescient examination and AI calculations, medical care suppliers can more readily recognize designs in understanding information and foster more precise gamble forecasts. With the assistance of information examination, suppliers can all the more likely comprehend the variables that add to patient results, like illness seriousness, treatment viability, and patient consistency. This, thusly, empowers suppliers to fit medicines to individual patient requirements, prompting work on quiet results. Moreover, information examination can assist with diminishing expenses by recognizing shortcomings and recommending elective medicines (Toussie et al. 2020). Finally, information research is a valuable tool that can assist medical services associations in making decisions that are more informed and working towards discreet outcomes. Data analytics in medical care alludes to the utilization of refined programs and calculations to recognize examples, patterns, and relationships in a lot of clinical information. This information can be used to work on the nature of patient consideration and lessen the expense of medical services. By dissecting the information, medical services suppliers can acquire significant experiences in patient well-being, clinical history, and side effects.

This data will be distinguish medical services patterns and arrive at better conclusions about quiet consideration. For example, through analysis data analytics utilized to foster prescient models that can assist with recognizing high-risk patients, propose therapies that are more viable, and diminish the probability of clinical blunders. Data analytics used to spot deceptive practices in healthcare and improve the efficiency of service delivery. By data analytics investigation, medical services suppliers can give better and more proper care to their patients. One of the critical advantages of analyzing clinical information is the capacity to foresee patient results.

In order to identify patients who may cause confusion or other adverse events, healthcare providers can use predictive investigation. (Chicco and Jurman 2020). For instance, by breaking down understanding information, medical services suppliers can foresee the probability of a patient developing a particular condition or the gamble of readmission after release. This data can assist medical care suppliers with mediating early, working on the possibilities of a positive result for the patient. Another region where analyzing clinical information can be advantageous is in clinical preliminaries. With the assistance of information examination, medical care suppliers can distinguish patient populations that are probably going to profit from a specific therapy or medication.

This can assist medical services suppliers with planning more successful clinical preliminaries, lessening the expense and time expected to offer new medications and therapies for sale to the public. Aside from patient consideration, analyzing clinical information can likewise be advantageous to medical services associations regarding cost investment funds. By investigating information, medical care suppliers can recognize regions where expenses diminished, like decreasing emergency clinic readmissions, keeping away from superfluous testing, and advancing asset use (Dennii et al. 2019). In addition, analyzing clinical information can likewise assist medical services suppliers with conforming to administrative prerequisites. For instance, medical services suppliers can utilize information investigation to screen consistency with patient security guidelines, track quality pointers, and guarantee that their activities follow administrative prerequisites.

General Data Protection Regulation(GDPR)

With regard to investigating clinical information to predict patient results, a few governance frameworks are important. These structures help to distinguish basic ethics, trust, and governance gives that emerge with regard to utilizing clinical data to make expectations about persistent results. This segment will be analyzed probably the most pertinent governance frameworks and assess their strengths and weaknesses.

The main administration structure we will look at is the General Data Protection Regulation (GDPR), which is a guideline from the European Association that happened in 2018. The GDPR frames rules for the assortment, handling, and capacity of individual information, including well-being information. It additionally lays out the privileges of people as for their own information (Ahmed et al. 2020). The GDPR is fundamental in guaranteeing that patients’ protection and that their information handled in a solid and moral way. The GDPR applied for those organizations, which categorized under the European Union (EU), to look out and for monitoring the EU resident’s behavior. This regulation is protect very carefully the personal data of all the citizens of EU and it also defines how the data is processed organizationally and how to keep the data in store and also how to destroy the data when it is not required as longer (Hu et al 2020). This process is also gives the right to the organizations that how the companies can use the data as it is needed per requirements and also give them a right which is specified as eight. In addition it can be said that GDPR regulations is laid very strict principles and rules due to if the data of citizens are get breached as it resulted the organization have to suffer a lot.

Data concerning health: The kinds of data which are relatable to a person’s health, which can be both mental and physical, is categorized as the data of concerning health and considered to be as protected and personal under the category of GDPR. This kind of data also includes the information that which rather care they received.

Genetic Data: Genetic makeup of any person’s is also a subject of the protection of GDPR and the information related to the genetic makeup. This genetic makeup is include the test results of labs which are related to the analysis of the sample of which is biological as well many other characteristics which can be reveal the health and physiology about the patient.

Biometric Data: The data related to the behavioral or any physical characteristics of someone is as referred as the biometric data. These kinds of data accepted as the personal data per GDRP thus it is use to be identify as anyone’s data specifically. This data must be include the fingerprints, facial images and more things like this.

The subject of the data must have to be a consent, which have to be explicit.

The processing is very much necessary in the case of occupational medicine or for the diagnosis of medicals.

The processing will be necessary for the reasons of the interest of the public in the area of the health of public.

Another pertinent administration structure is the Health Insurance Portability and Accountability Act (HIPAA), which is a US regulation that directs the treatment of protected health information (PHI). HIPAA gives a bunch of principles to safeguarding the secrecy, uprightness, and accessibility of PHI. It likewise lays out the freedoms of people to get to their PHI and sets necessities for break notice. HIPAA is essential in guaranteeing that patients’ well-being data dealt with fittingly and that their security.

A third pertinent administration structure is the Ethical, Legal, and Social Implications (ELSI) program, which is a program laid out by the National Human Genome Research Institute (NHGRI) to address the moral, lawful, and social ramifications of genomic research. The ELSI program centered on understanding the effect of genomic research on people and society and tending to moral, lawful, and social issues that emerge with regard to genomic research (Dashi et al. 2019). The ELSI program is fundamental in guaranteeing that clinical information utilized in a moral and dependable way.

While these administration systems have qualities in safeguarding patients’ protection and guaranteeing that clinical information utilized in a moral way, they likewise have shortcomings. For instance, GDPR and HIPAA centered fundamentally on safeguarding patients’ protection, yet they do not resolve more extensive moral issues connected with the utilization of clinical information, like inclination or segregation. The ELSI program centered on genomic research and may not be genuine relevant to different kinds of clinical information.

To address these shortcomings, a mixture of these structures created to make a more complete administration system. This system ought to address security worries as well as more extensive moral issues connected with the utilization of clinical information. It ought to consider the quickly advancing nature of clinical information and innovation.

Clinical Information

Utilizing the combined system examined in the past segment, we can fundamentally assess the setting of breaking down clinical information to foresee patient results and recognize basic weaknesses that require areas of strength for another methodology.

One basic vulnerability is the potential for predisposition in clinical information. Clinical information can be one-sided in light of elements like race, orientation, age, and financial status. This tendency may lead to inaccurate predictions of future outcomes and may exacerbate well-being disparities (Manne and Kantheti 2021). To address this weakness, another administration technique ought to incorporate measures to recognize and alleviate predisposition in clinical information. This can incorporate procedures, for example, information approval, utilizing assorted datasets, and guaranteeing that calculation used to examine the information are straightforward and logical.

Another basic weakness is the potential for breaks in patient security. As clinical information turns out to be all the more broadly utilized and available, there is an expanded gamble of information penetration that can think twice about security. Another administration procedure ought to incorporate measures to safeguard patient protection, for example, executing solid information safety efforts and guaranteeing that admittance to clinical information is restricted to approve faculty as it were.

A third basic weakness is the potential for abuse of clinical information. Clinical information utilized for purposes other than anticipating patient results, for example, promoting or protection guaranteeing (Attia et al. 2019). This can bring about moral worries and can dissolve patient confidence in the medical care framework. Another administration procedure ought to incorporate measures to forestall the abuse of clinical information, for example, growing clear rules and strategies for the utilization of clinical information and guaranteeing that patients have command over how their information utilized.

At last, a basic weakness is the absence of straightforwardness in how clinical information utilized. Patients may not know how their information being utilized or may not grasp the likely ramifications of sharing their information. Another administration methodology ought to incorporate measures to increment straightforwardness and advance patient comprehension of how their information utilized. This can incorporate growing clear and brief patient schooling materials and furnishing patients with the capacity to control how their information utilized.

The setting of dissecting clinical information to foresee patient results has a few basic weaknesses that require areas of strength for another methodology. These weaknesses remember a predisposition for clinical information, breaks of patient protection, abuse of clinical information, and absence of straightforwardness. To address these weaknesses, another administration procedure ought to incorporate measures to distinguish and moderate predisposition, safeguard patient security, forestall the abuse of clinical information, and increment straightforwardness (Islam et al. 2020). By carrying out areas of strength for a methodology, we can guarantee that clinical information utilized in a moral and mindful way and that patients’ security and confidence in the medical services framework.

Avoiding Fraud and Abuse

Applying the synthesized and justified framework system to the critical vulnerabilities recognized in section 1.3, they can propose administration techniques to relieve those weaknesses and guarantee that breaking down clinical information to foresee patient results is finished in a moral and dependable way.

Firstly, to moderate the potential for predisposition in clinical information, an administration system ought to incorporate measures to guarantee that information utilized for examination is assorted and delegated to various populations. This can be accomplished by gathering information from a scope of sources, including underrepresented gatherings, and utilizing proper measurable strategies to represent any irregular characteristics in the information (Huang et al. 2019). Moreover, calculations used to dissect the information ought to be straightforward and logical, and their results ought to examine to guarantee that inclination is not being brought into the investigation.

Furthermore, to safeguard patient protection and forestall breaks of clinical information, an administration technique ought to incorporate solid information safety efforts. This can incorporate encoding patient information, carrying out access controls to restrict who approaches the information, and routinely examining access logs to distinguish and explore any dubious movement. Moreover, any outsider sellers or project workers who handle clinical information ought to be expected to follow severe information security conventions, and there ought to be customary evaluations of their consistency with those conventions.

Thirdly, to prevent the abuse of clinical information, an administration procedure ought to incorporate strategies and rules that unequivocally deny the utilization of clinical information for purposes other than anticipating patient results (Chen et al. 2020). These approaches ought to convey obviously to all partners, including patients, and implement thoroughly. Patients ought to give command over how their information is utilize, and their assent ought to get before their information imparted to any outsiders. The physician’s majority which is vast works very potentially and ethnically to provide the high quality of health care to the patients and claim the appropriate payment from them but somebody of them don’t work in this way. To identify those persons who are use the system of health care for gain personally, a law is regulate for them. That is to protect the fraud and abuse through the integrity of payment system of the health care. The act or law that is the most important applied for the physicians that is False Claims Act consists from American Federal Law, Self-Referral Law of Physicians; the statue of Anti-Kickback and the Law of Monetary Penalties is Civil (Esteva et al 2019). For not doing, the anything wrong there is a sudden penalty is there if the law is broken. Medicaid, Medicare and other programs of health care which will be federal and also the private payers are focused on this thing that the physicians are providing the proper treatment and give the proper judgment to the patient. In addition, claiming the accurate payment after the service they provide to the patient. Taken a program of compliance is one of the best way to avoid such kinds of fraud and abuse from the workplace and protect it (Jiang et al 2020). The organizations of health care which are very large is always have this place since many years long and the physicians who are working in these organizations they are aware very much about what are their responsibilities are in that program.

Finally, to increment straightforwardness and advance patient comprehension of how their information utilized an administration methodology ought to incorporate measures to convey obviously and successfully with patients. Patients should be clear and straightforward about how their information is handle and any possible repercussions of giving it. Furthermore, patients ought to provide with the capacity to access and survey their own clinical information, and they ought to have the option to demand revisions or adjustments to that information if fundamental.

A solid administration procedure is fundamental to guarantee that examining clinical information to foresee patient results is finished in a moral and capable way. To relieve the basic weaknesses distinguished in Section 3, an administration methodology ought to incorporate measures to guarantee information variety, solid information security, strategies to forestall abuse of clinical information, and clear correspondence with patients to advance straightforwardness and understanding (Tan et al. 2020). By carrying out these administration methodologies, we can guarantee that clinical information is utilized for its planned reason while safeguarding patient protection and advancing confidence in the medical services framework.

A best way to avoid such abuse and fraud in the sectors of health care is to take or set a program of compliance. The healthcare organizations which are very large they already have this program since many years back and the physicians of there is known about their responsibilities in the compliance program. According to the act of Patient Protection and Affordable Care 2010, the all physicians have to be establish a program of compliance who are treating the beneficiaries of Medicaid and Medicare (Domingo et al. 2021). Even the practices, which are very small, can also participate in this program.

A program of the compliance is a net, which is safe also. This program is established for to prevent strategies and to detect and resolve those conducts which are not conformed to the federal and the state and the ethics which is own and the policy of business practices. It is also means that you are literally follow the rules and the regulations and trying to improve your work. Additionally it can be said that if there a complaint will lodged then it will allows you to show your demonstrate what you have and a process which should be followed.

As per the Inspector General’s HHS officer the program of the compliance has 7 elements. Below is a description of them.

Have to conduct the auditing and the monitoring which is internal.
To implement the compliance which is written and the standards of practice.
Have to design an officer of compliance, committee or contact.
Have to conduct a training, which is appropriate, and an ongoing education.
Must respond appropriately to identify crimes and create the appropriate course of action.
The lines of communication, which is open, need to develop.
Enforce the standards of disciplinary through the guidelines which is well publicized

The following below are some of the examples of fraud of healthcare, which are very much common and may be you can encounter with this frauds and you should have to report about this such types of frauds.

The service or treatment that give to patients may be misrepresent.
The service of rendering which is individual can also represent by physicians in a false manner.
Billing for those items and those services which are not rendered as well
No proper documentation of bills for the services, which are provided to the patient.
Make a bill for those items, which are not necessary as medically.
The payments seeking or seeking the reimbursement for the services which is provided for rendering the procedures which are basically integral to the other procedures which are performed on same date when the service is provided.
The seeking of the payment, which is increased, or the services, which is provided for reimbursement that should need to make a correct bill with a lower rate.

On the other hand, abuse is known as those practices, which are, includes the business mottos. Sometimes sound likes fiscal or the practices of medicals and as all over the result is in a cost, which is unnecessary, or in the reimbursement for the services which is provided and that is not much necessary medically or even failed to be meet the standards which is recognized professionally for the health care.

Misuse the codes for claiming.
Excessive charges for the supplies and the services, which is not exactly provided to the patient.
Billing for those services, which are not much necessary in medical.

Fraud and abuse are both regard as civil and criminal offences that expose the seller or the suppliers.

The initiatives taken by the providers of the Insurance

The insurance companies are taking various steps for avoiding such frauds from the few years past where the healthcare claimed as fraud. The insurance companies, which are leading, put the verification, which is very much strict, and the processes of approval in the place and leverage the technologies to identify the fraud cases in a better way. In some situations the insurance companies are also identify the claims of fraud through a region, which have very high concentration on the cases of fraud claims, and then blacklist those pin codes (Wang et al. 2020.).

On the other hand, the bodies of regulatory system is attempt to centralize the databases of institute and to promote the sharing of the information in the industry of the healthcare. However if there is any kind of significant measures may be create an impact on the national scale, the providers of the insurance have to need to be implement a strategy of fraud detection which will be integral and the framework which is foundational for the industry.

Challenges of fraud prevention: Technological advancements and data analysis

Abuse and fraud both are came in different disguises. The various process improvements and the modification in them are always raised a trigger but only one thing is very common which is very much effective to detect the cases of fraud is the analysis of data.

The providers of the insurance can be extract the intelligence which is actionable with taking the help of the advanced data analytical tools, form the models which are predictive and also flag those which may be committed to be fraud.

Hence the provider of the health insurance across all over the world are looking out for the development of the new and the more tools which are sophisticated and to be predict the frauds and to mitigate the risks. Going through use of the data points which are traditional, information which are gathered from the alternative sources are harnessed, that things are get available by the adoption of the technology which is digital from the last few years (Piccolo et al.2019).

For the real time monitoring the information could be collected from the social media or from the mobile and also from the other wearable devices for identifying the policyholder when his/her claims are so not consistent much with her/his behavior. Not only this process and technologies are help so much to detect the frauds and the abuses but also offer different kinds of various opportunities for the insurance industry of healthcare to be tap into it. Claiming the poses of fraud as a very much considerable challenge for the insurance industry of healthcare. There is an approach, which is not only integrated but also comprehensive to be continue the management of risks.

Fraud Prevention in Healthcare

Medical data analysis’ integrity is seriously threaten by fraud in the healthcare industry. It covers things like bogus claim submissions, identity theft, and billing fraud. Fraudulent actions not only lead to financial losses but may also have an effect on patient treatment and results. The significance of fraud prevention strategies in the healthcare industry as well as the demand for cutting-edge technology to identify and discourage fraudulent activity have been emphasize in several studies.

Technological Advancements in Fraud Detection

Enhancing healthcare, fraud prevention skills made possible in large part by technological improvements. The use of cutting-edge technology, including machine learning, artificial intelligence, and data mining, in fraud detection is examined in this portion of the literature review. With the aid of these technologies, it is possible to analyse huge amounts of healthcare data, spot suspicious trends or abnormalities, and foresee probable fraud situations. Numerous studies have shown how well these technologies work in identifying fraudulent activity in healthcare settings.

Data Analysis for Predicting Patient Outcomes

Techniques for data analysis have been extremely useful in forecasting patient outcomes and enhancing healthcare decision-making. This section focuses on the use of data analysis techniques, such as predictive modelling, risk stratification, and outcome prediction, to improve patient care. Healthcare professionals may identify patients at risk of negative outcomes, create individualized treatment plans, and optimise resource allocation by analyzing medical data, such as electronic health records, test findings, and patient demographics. However, when fraudulent actions sabotage the data’s integrity, the accuracy and dependability of data analysis putting in danger.

Challenges of Fraud Prevention in Data Analysis

Although there are significant potential for fraud prevention and predicting patient outcomes thanks to technology improvements and data analysis methods, there are still certain difficulties to solve. Key issues are highlight in this section, such as data quality and integrity issues, privacy issues, algorithm bias, and the ongoing development of fraudulent strategies. For successful fraud detection and the forecasting of patient outcomes, medical data must be ensure to be accurate and reliable. To uphold patient confidence and abide by legal standards, privacy concerns relating to the usage of sensitive healthcare data must be address. Furthermore, fraud prevention attempts are continually hamper by algorithm bias and criminals’ capacity to adopt new technology and detection techniques.

References

Ahmed, Z., Mohamed, K., Zeeshan, S. and Dong, X., 2020. Artificial intelligence with multi-functional machine learning platform development for better healthcare and precision medicine. Database, 2020.
Attia, Z.I., Noseworthy, P.A., Lopez-Jimenez, F., Asirvatham, S.J., Deshmukh, A.J., Gersh, B.J., Carter, R.E., Yao, X., Rabinstein, A.A., Erickson, B.J. and Kapa, S., 2019. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction. The Lancet, 394(10201), pp.861-867.
Chen, R., Liang, W., Jiang, M., Guan, W., Zhan, C., Wang, T., Tang, C., Sang, L., Liu, J., Ni, Z. and Hu, Y., 2020. Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China. Chest, 158(1), pp.97-105.
Chicco, D. and Jurman, G., 2020. Machine learning can predict survival of patients with heart failure from serum creatinine and ejection fraction alone. BMC medical informatics and decision making, 20(1), pp.1-16.
Dash, S., Shakyawar, S.K., Sharma, M. and Kaushik, S., 2019. Big data in healthcare: management, analysis and future prospects. Journal of Big Data, 6(1), pp.1-25.
Dennis, J.M., Shields, B.M., Henley, W.E., Jones, A.G. and Hattersley, A.T., 2019. Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. The lancet Diabetes & endocrinology, 7(6), pp.442-451.
Domingo, P., Mur, I., Mateo, G.M., del Mar Gutierrez, M., Pomar, V., de Benito, N., Corbacho, N., Herrera, S., Millan, L., Muñoz, J. and Malouf, J., 2021. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis. Jama, 326(6), pp.499-518.
Esteva, A., Robicquet, A., Ramsundar, B., Kuleshov, V., DePristo, M., Chou, K., Cui, C., Corrado, G., Thrun, S. and Dean, J., 2019. A guide to deep learning in healthcare. Nature medicine, 25(1), pp.24-29.
Hu, L., Chen, S., Fu, Y., Gao, Z., Long, H., Ren, H.W., Zuo, Y., Wang, J., Li, H., Xu, Q.B. and Yu, W.X., 2020. Risk factors associated with clinical outcomes in 323 coronavirus disease 2019 (COVID-19) hospitalized patients in Wuhan, China. Clinical infectious diseases, 71(16), pp.2089-2098.
Hu, L., Chen, S., Fu, Y., Gao, Z., Long, H., Ren, H.W., Zuo, Y., Wang, J., Li, H., Xu, Q.B. and Yu, W.X., 2020. Risk factors associated with clinical outcomes in 323 coronavirus disease 2019 (COVID-19) hospitalized patients in Wuhan, China. Clinical infectious diseases, 71(16), pp.2089-2098.
Huang, L., Shea, A.L., Qian, H., Masurkar, A., Deng, H. and Liu, D., 2019. Patient clustering improves efficiency of federated machine learning to predict mortality and hospital stay time using distributed electronic medical records. Journal of biomedical informatics, 99, p.103291.
Ishaq, A., Sadiq, S., Umer, M., Ullah, S., Mirjalili, S., Rupapara, V. and Nappi, M., 2021. Improving the prediction of heart failure patients’ survival using SMOTE and effective data mining techniques. IEEE access, 9, pp.39707-39716.
Islam, M.M., Ferdousi, R., Rahman, S. and Bushra, H.Y., 2020. Likelihood prediction of diabetes at early stage using data mining techniques. In Computer vision and machine intelligence in medical image analysis(pp. 113-125). Springer, Singapore.
Islam, M.M., Ferdousi, R., Rahman, S. and Bushra, H.Y., 2020. Likelihood prediction of diabetes at early stage using data mining techniques. In Computer vision and machine intelligence in medical image analysis(pp. 113-125). Springer, Singapore.
Jiang, X., Coffee, M., Bari, A., Wang, J., Jiang, X., Huang, J., Shi, J., Dai, J., Cai, J., Zhang, T. and Wu, Z., 2020. Towards an artificial intelligence framework for data-driven prediction of coronavirus clinical severity. Computers, Materials & Continua, 63(1), pp.537-551.
Manne, R. and Kantheti, S.C., 2021. Application of artificial intelligence in healthcare: chances and challenges. Current Journal of Applied Science and Technology, 40(6), pp.78-89.
Manne, R. and Kantheti, S.C., 2021. Application of artificial intelligence in healthcare: chances and challenges. Current Journal of Applied Science and Technology, 40(6), pp.78-89.
Piccolo, R., Bonaa, K.H., Efthimiou, O., Varenne, O., Baldo, A., Urban, P., Kaiser, C., Remkes, W., Raeber, L., de Belder, A. and van’t Hof, A.W., 2019. Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials. The Lancet, 393(10190), pp.2503-2510.
Shilo, S., Rossman, H. and Segal, E., 2020. Axes of a revolution: challenges and promises of big data in healthcare. Nature medicine, 26(1), pp.29-38.
Tan, C., Huang, Y., Shi, F., Tan, K., Ma, Q., Chen, Y., Jiang, X. and Li, X., 2020. C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early. Journal of medical virology, 92(7), pp.856-862.
Toussie, D., Voutsinas, N., Finkelstein, M., Cedillo, M.A., Manna, S., Maron, S.Z., Jacobi, A., Chung, M., Bernheim, A., Eber, C. and Concepcion, J., 2020. Clinical and chest radiography features determine patient outcomes in young and middle-aged adults with COVID-19. Radiology, 297(1), pp.E197-E206.
Toussie, D., Voutsinas, N., Finkelstein, M., Cedillo, M.A., Manna, S., Maron, S.Z., Jacobi, A., Chung, M., Bernheim, A., Eber, C. and Concepcion, J., 2020. Clinical and chest radiography features determine patient outcomes in young and middle-aged adults with COVID-19. Radiology, 297(1), pp.E197-E206.
Vijenthira, A., Gong, I.Y., Fox, T.A., Booth, S., Cook, G., Fattizzo, B., Martín-Moro, F., Razanamahery, J., Riches, J.C., Zwicker, J. and Patell, R., 2020. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood, 136(25), pp.2881-2892.
Vijenthira, A., Gong, I.Y., Fox, T.A., Booth, S., Cook, G., Fattizzo, B., Martín-Moro, F., Razanamahery, J., Riches, J.C., Zwicker, J. and Patell, R., 2020. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood, 136(25), pp.2881-2892.
Wang, Y., Lu, X., Li, Y., Chen, H., Chen, T., Su, N., Huang, F., Zhou, J., Zhang, B., Yan, F. and Wang, J., 2020. Clinical course and outcomes of 344 intensive care patients with COVID-19. American journal of respiratory and critical care medicine, 201(11), pp.1430-1434.
Zhang, B., Zhou, X., Zhu, C., Song, Y., Feng, F., Qiu, Y., Feng, J., Jia, Q., Song, Q., Zhu, B. and Wang, J., 2020. Immune phenotyping based on the neutrophil-to-lymphocyte ratio and IgG level predicts disease severity and outcome for patients with COVID-19. Frontiers in molecular biosciences, 7, p.157.